-Yasuo Ikeda Researcher Activity Profile

Research Author Detailed Information 

Yasuo Ikeda Publication Rate By Year

Yasuo Ikeda has published 1 paper(s) in 2002, 1 paper(s) in 2005, 1 paper(s) in 2006, 9 paper(s) in 2007, 7 paper(s) in 2008, for a total of 19 research publications in total.

Yasuo Y Ikeda Author Information

LAST NAME: ikeda

FIRST NAME: yasuo

INITIALS: Y

AFFILIATION:

Papers

Yasuo Ikeda's Publication Record

1. Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells. Year Published: 2002
Division of Hematology, Keio University School of Medicine, Tokyo, Japan.
2. Lineage-specific expression of granulocyte colony-stimulating factor and thrombopoietin receptors in terminally differentiated hematopoietic cells. Year Published: 2006
Pharmaceutical Development Laboratories, Kirin Brewery Co., Ltd., Gunma, Japan. tkuwaki@kirin.co.jp
3. Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Year Published: 2007
Division of Hematology, Department of Internal Medicine, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
4. A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency. Year Published: 2007
Research Institute, National Cardiovascular Center, Osaka, Japan.
5. Targeting NF-kappaB and induction of apoptosis by novel NF-kappaB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells. Year Published: 2007
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
6. Targeting NF-kappaB and induction of apoptosis by novel NF-kappaB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells. Year Published: 2007
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
7. [Classification and mechanism of adverse drug reaction] Year Published: 2007
Division of Hematology, Department of Internal Medicine, Keio University, School of Medicine.
8. [Drug-induced pancytopenia] Year Published: 2007
Division of Hematology, Department of Internal Medicine, Keio University, School of Medicine.
9. Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Year Published: 2007
Division of Hematology, Department of Internal Medicine, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
10. Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole. Year Published: 2008
Division of Hematology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
11. A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency. Year Published: 2007
Research Institute, National Cardiovascular Center, Osaka, Japan.
12. Atomic XAFS as a tool to probe the electronic properties of supported noble metal nanoclusters. Year Published: 2005
Department of Inorganic Chemistry and Catalysis, Debye Institute, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands.
13. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: Possible anti-myeloma mechanism of thalidomide. Year Published: 2008
Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
14. Targeting NF-kappaB and induction of apoptosis by novel NF-kappaB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells. Year Published: 2007
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
15. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Year Published: 2008
Department of Rheumatology, Toho University Ohashi Medical Center, 2-17-6 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan, saito@oha.toho-u.ac.jp.
16. Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms. Year Published: 2008
The Keio-Daiichi Project on Genetics of Thrombosis, Keio University, Tokyo 160-8582, Japan; Biological Research Laboratories I, DAIICHI SANKYO Co., Ltd., Tokyo 134-8630, Japan.
17. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide. Year Published: 2008
Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
18. A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. Year Published: 2008
Ashikaga Red Cross Hospital, Ashikaga, Japan. y.fukuuchi@ashikaga.jrc.or.jp
19. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Year Published: 2008
Department of Rheumatology, Toho University Ohashi Medical Center, Tokyo, Japan. saito@oha.toho-u.ac.jp